Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease

Liver disease
DOI: 10.1152/ajpgi.00047.2024 Publication Date: 2024-04-16T15:23:30Z
ABSTRACT
Patients with autoimmune liver disease but without overt diabetes display glucose disturbances early on in their course. We identified pathophysiological traits specific to these patients including altered incretin responses.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (59)
CITATIONS (3)